Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Transgene sells Tasly its stake in Transgene Tasly (Tianjin) JV

Executive Summary

Transgene SA is selling Tasly Biopharmaceuticals Co. Ltd. its 50% stake of their equally owned Transgene Tasly (Tianjin) BioPharmaceutical Co. virus-based immunotherapies joint venture (formed in 2010), giving Tasly a 100% ownership of the JV.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Acquisition of Private Biotech
    • Intra-Biotech Deal
    • Partial Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register